Carbamazepine level-A in vivo-in vitro correlation (IVIVC): a scaled convolution based predictive approach

Area of Science:

• Pharmacokinetics
• Drug Delivery Systems
• Computational Modeling

Background:

• Predicting systemic drug concentration from in vitro data is crucial for drug development.
• Existing methods often lack accuracy or require extensive validation.
• Carbamazepine (CZM) is a widely used antiepileptic drug with variable bioavailability.

Purpose of the Study:

• To develop and validate a novel method for predicting in vivo drug concentration profiles from in vitro dissolution data.
• To establish an in vivo-in vitro correlation (IVIVC) for carbamazepine formulations.
• To assess the prediction accuracy of the proposed method using cross-validation.

Main Methods:

• Four carbamazepine tablet formulations were tested in 20 human subjects.
• In vitro dissolution data were obtained using a standard paddle method.
• Dissolution rate curves were derived from dissolution data using spline fitting.
• Convolution with a single exponential and impulse response function mapped dissolution to concentration.

Main Results:

• The method successfully predicted in vivo concentration profiles with a mean prediction error (MPE) of 22% (S.D. 13%).
• Cross-validation demonstrated good predictive performance across different formulations.
• The established IVIVC model showed robust correlation between in vitro and in vivo data.

Conclusions:

• The proposed method provides a reliable approach for predicting systemic drug concentration from in vitro dissolution data.
• This IVIVC method can aid in optimizing drug formulation and reducing the need for extensive clinical trials.
• The findings support the utility of this predictive model in pharmaceutical research and development.